Related Experiment Videos
NSAIDs and chemoprevention.
Chinthalapally V Rao1, Bandaru S Reddy
1Chemoprevention Program, Institute For Cancer Prevention, American Health Foundation-Cancer Center, 1 Dana Road, Valhalla, NY 10595, USA. crao@ifcp.us
Current Cancer Drug Targets
|February 18, 2004
Summary
Nonsteroidal anti-inflammatory drugs (NSAIDs) show promise in cancer chemoprevention by reducing tumor cell growth and proliferation. Research explores their mechanisms and innovative applications for improved cancer prevention and treatment strategies.
Area of Science:
- Oncology
- Pharmacology
Background:
- Nonsteroidal anti-inflammatory drugs (NSAIDs) are recognized for their potential in cancer chemoprevention.
- Long-term NSAID use is linked to reduced risks of various cancers, including gastrointestinal, breast, prostate, lung, and skin cancers.
Purpose of the Study:
- To elucidate the mechanisms by which NSAIDs regulate tumor cell growth and proliferation.
- To explore the role of NSAIDs, particularly selective cyclooxygenase-2 (COX-2) inhibitors, in cancer prevention and treatment strategies.
Main Methods:
- Review of epidemiological, clinical, and experimental studies on NSAIDs and cancer.
- Analysis of NSAID effects on apoptosis, cell proliferation, and angiogenesis in various cancer models.
- Exploration of novel approaches, including combination therapies and nitric oxide-releasing NSAIDs.
Main Results:
- NSAIDs restore normal apoptosis and reduce cell proliferation in colorectal polyps, tumors, and cancer cell lines.
- Selective COX-2 inhibitors demonstrate inhibition of angiogenesis.
- Innovative strategies like combination therapy and nitric oxide-releasing NSAIDs aim to enhance efficacy and minimize toxicity.
Conclusions:
- NSAIDs offer significant insights into cancer regulation, prevention, and treatment.
- Further research is needed to address safety, efficacy, and optimal regimens for clinical application.
- Optimized NSAID-based strategies hold promise for reducing cancer mortality and morbidity.